Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.

Ichikawa, Kosuke; Kagamu, Hiroshi; Koyama, Kenichi; Miyabayashi, Takao; Koshio, Jun; Miura, Satoru; Watanabe, Satoshi; Yoshizawa, Hirohisa; Narita, Ichiei

Ichikawa, Kosuke; Kagamu, Hiroshi; Koyama, Kenichi; Miyabayashi, Takao; Koshio, Jun; Miura, Satoru; Watanabe, Satoshi; Yoshizawa, Hirohisa; Narita, Ichiei.

Affiliation

Ichikawa K; Division of Respiratory Medicine, Department of Homeostatic Regulation and Development, Course for Biological Functions and Medical Control, Graduate School of Medical and Dental Sciences, Niigata University, Japan.

Vaccine ; 30(43): 6190-7, 2012 Sep 21.

Article in En | MEDLINE | ID: mdl-22889826

Subject(s)

Antigens, Neoplasm/immunology; Dendritic Cells/immunology; Epitopes, T-Lymphocyte/immunology; Fibrosarcoma/immunology; Th1 Cells/immunology; Th17 Cells/immunology; Animals; Antigen Presentation; Apoptosis; Autocrine Communication; Cell Line, Tumor; Female; Humans; Interleukin-23/immunology; Mice; Mice, Inbred C57BL; Mice, Transgenic; T-Lymphocytes, Regulatory/immunology; Th2 Cells/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Dendritic Cells / Th1 Cells / Epitopes, T-Lymphocyte / Th17 Cells / Fibrosarcoma / Antigens, Neoplasm Limits: Animals / Female / Humans Language: En Journal: Vaccine Year: 2012 Type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google